Active peptide angiotensin II (Ang II), converted from the inactive decapeptide Ang I from the renin-angiotensin-system (RAS), can lead to chronic tissue injury, hypertension and vasoconstriction through the JAK–STAT signaling pathway. The gene discussed is AGT; the disease is hypertensive disorder.